BALASSA LABORATORIES INC. – Trademark Portfolio
Entity Type: 03
BALASSA LABORATORIES INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include CORNSTICK, WARTSTICK, CORN STICK, SOLARSTICK, and WART STICK. The owner is based in Ormond Beach, FL.
428 Chelsea Place Ave.
Ormond Beach, FL 32174
Showing of trademarks Trademarks
Trademark Classifications
BALASSA LABORATORIES INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does BALASSA LABORATORIES INC. have?
BALASSA LABORATORIES INC. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned, 2 cancelled.
What trademark classes does BALASSA LABORATORIES INC. file in?
BALASSA LABORATORIES INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BALASSA LABORATORIES INC.'s most well-known trademarks?
BALASSA LABORATORIES INC.'s registered trademark portfolio includes well-known marks such as CORNSTICK, WARTSTICK, CORN STICK, SOLARSTICK, and WART STICK. These are among 7 currently registered trademarks in the portfolio.
What is BALASSA LABORATORIES INC.'s trademark registration success rate?
BALASSA LABORATORIES INC. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.